Back to Agenda
S03 : The Potential of Novel Partnerships to Accelerate Drug Development for Rare Diseases
Session Chair(s)
Yojiro Sato
Regulatory Affairs, Janssen Pharmaceutical K.K., Japan
Speaker(s)
Osamu Asano
Senior Director, Regulatory Affairs, Alexion Pharma GK, Japan
SUSUMU KITAMURA
Head of Global Regulatory Affairs, Sanofi, Japan
Michio Ozeki
Associate Professor, Gifu University Hospital, Japan
Akifumi Kamata, PhD
Office of New Drug I, Pharmaceuticals and Medical Devices Agency, Japan
Have an account?